covid 19 News and Research

RSS

Study uncovers protein 'signature' of severe COVID-19

Researchers at Massachusetts General Hospital have identified the protein "signature" of severe COVID-19, which they describe in a new study published in Cell Reports Medicine.

4 May 2021

Individuals with intellectual disabilities faced triage biases during COVID-19 pandemic

When COVID-19 patients began filling up ICUs throughout the country in 2020, health care providers faced difficult decisions. Health care workers had to decide which patients were most likely to recover with care and which were not so resources could be prioritized.

4 May 2021

A multipronged approach to mitigate childhood adversity and build resiliency

A hot topic symposia session during the Pediatric Academic Societies 2021 Virtual Meeting will discuss a multipronged approach to addressing childhood adversity and promoting resilience - at the clinical, systems, community and educational levels.

4 May 2021

Stomach-specific protein plays a key role in the progression of obesity

Scientists believe a stomach-specific protein plays a major role in the progression of obesity, according to new research in Scientific Reports.

4 May 2021

Wyss Institute licenses nasal swab collection technology to Massachusetts-based startup

The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University's sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.

4 May 2021

Researchers identify mechanism of platelet hyperactivation in COVID-19 patients

A recent study conducted at the University of Pennsylvania and the Children’s Hospital of Philadelphia, USA, has revealed the mechanism of platelet hyperactivation in critically ill coronavirus disease 2019 (COVID-19) patients.

4 May 2021

Researchers improve HIV care using mobile gaming application

Researchers at the University of North Carolina at Chapel Hill and Duke University improved HIV care by gamifying it with a mobile gaming application.

4 May 2021

What happens in the first few days of SARS-CoV-2 infection?

New research, published in PLOS Biology, has evaluated SARS-CoV-2 infection in primary cultures of well-differentiated cells to determine how the virus affects the body and how the infection starts. Answers to these questions are essential to forming a general understanding of viral pathogenesis, which helps us develop effective prevention and treatment strategies for COVID-19.

4 May 2021

Can SARS-CoV-2’s impairment of endothelium cause vascular disease?

The study, published in the journal Circulation Research, suggests that COVID-19 is not only a respiratory disease but also a vascular disease. It highlights how the virus attacks the vascular system, causing endothelial impairment.

4 May 2021

Moderna COVID-19 vaccine makes it on WHO Emergency Use Listing

Moderna has announced Emergency Use Listing granted by the World Health Organization for its COVID-19 mRNA vaccine.

4 May 2021

COVID-19 in pregnancy does not significantly increase respiratory illness in newborns, says study

A new study published in the journal JAMA offers reassuring evidence that infants born to mothers with coronavirus disease 2019 (COVID-19), or even asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have little increase in respiratory symptoms over babies born to uninfected mothers.

4 May 2021

Critical care nurses in poor physical and mental health report more medical errors

A study led by The Ohio State University College of Nursing finds that critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health.

4 May 2021

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

A vexing problem in the development of vaccines has been the need to achieve the right glycosylation profile for the viral antigens. A new study, recently released as a preprint on the bioRxiv* server, shows how a sequential cell-free approach produced complex N-glycans from simpler types, in a one-pot reaction.

4 May 2021

Covid ‘doesn’t discriminate by age’: Serious cases on the rise in younger adults

After spending much of the past year tending to elderly patients, doctors are seeing a clear demographic shift: young and middle-aged adults make up a growing share of the patients in covid-19 hospital wards.

4 May 2021

One in five older adults experienced worse mental health since the pandemic

Nearly one in five older adults say their mental health has gotten worse since the pandemic began in March 2020, and an equal percentage say their sleep has suffered in that time too.

4 May 2021

Conspiracies beliefs about COVID-19 increased among users of conservative and social media

Belief in conspiracies about the COVID-19 pandemic increased through the early months of the U.S. outbreak among people who reported being heavy users of conservative and social media, a study by Annenberg Public Policy Center (APPC) researchers has found.

4 May 2021

Rapid and sensitive SARS-CoV-2 detection from saliva using CRISPR

In a paper recently uploaded to the preprint server medRxiv by Edward Málaga Trillo et al. (April 29th, 2021), these methods are tested in combination with CRISPR-Cas detection in the field, demonstrating a sensitivity and specificity of 93.8% and 99%, respectively.

4 May 2021

New computational tool helps screen molecules for their potential COVID-fighting properties

A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-CoV-2.

4 May 2021

Uncertainty during first COVID-19 lockdown had negative impact on mental health

Many people in Switzerland experienced considerable psychological distress during the first COVID-19 lockdown from mid-March to the end of April 2020.

4 May 2021

Evidence that elevated blood glucose is a significant risk factor for severe COVID-19

The literature analysis pointed to elevated blood glucose levels as a leading facilitator in the progression of COVID-19. Evidence linking elevated glucose to various steps in the life cycle of the virus and presentation of COVID-19 symptoms were also found.

3 May 2021

covid 19 News and Research

Study uncovers protein 'signature' of severe COVID-19

Individuals with intellectual disabilities faced triage biases during COVID-19 pandemic

A multipronged approach to mitigate childhood adversity and build resiliency

Stomach-specific protein plays a key role in the progression of obesity

Wyss Institute licenses nasal swab collection technology to Massachusetts-based startup

Researchers identify mechanism of platelet hyperactivation in COVID-19 patients

Researchers improve HIV care using mobile gaming application

What happens in the first few days of SARS-CoV-2 infection?

Can SARS-CoV-2’s impairment of endothelium cause vascular disease?

Moderna COVID-19 vaccine makes it on WHO Emergency Use Listing

COVID-19 in pregnancy does not significantly increase respiratory illness in newborns, says study

Critical care nurses in poor physical and mental health report more medical errors

Could in vitro glycoengineering help produce better SARS-CoV-2 spike candidates for vaccine research?

Covid ‘doesn’t discriminate by age’: Serious cases on the rise in younger adults

One in five older adults experienced worse mental health since the pandemic

Conspiracies beliefs about COVID-19 increased among users of conservative and social media

Rapid and sensitive SARS-CoV-2 detection from saliva using CRISPR

New computational tool helps screen molecules for their potential COVID-fighting properties

Uncertainty during first COVID-19 lockdown had negative impact on mental health

Evidence that elevated blood glucose is a significant risk factor for severe COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News